CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise 10b5-1 | +4,861 | $21.34 | $104K | 108,474 |
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −4,861 | $38.03 | $185K | 103,613 |
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −4,861 | 16,389 | ||
| 2025-08-13 | Rubric Capital Management LP 10% owner | Sale | −25,000 | $37.85 | $946K | 3,132,743 |
| 2025-08-08 | Freund John Gordon Director | Sale | −11,659 | $34.36 | $401K | 23,129 |
| 2025-06-09 | Freund John Gordon Director | Option exercise | +15,000 | $13.45 | $202K | 77,259 |
| 2025-06-09 | Freund John Gordon Director | Sale | −6,601 | $30.62 | $202K | 70,658 |
| 2025-06-09 | Freund John Gordon Director | Option exercise · Stock Option (Right to Purchase) | −15,000 | 0 | ||
| 2025-05-15 | Fallon John A. Director | Grant or award | +9,791 | 64,634 | ||
| 2025-05-15 | Lurker Nancy Director | Grant or award | +9,791 | 22,517 | ||
| 2025-05-15 | BOHLIN GAREN G Director | Grant or award | +9,791 | 62,259 | ||
| 2025-05-15 | Balice-Gordon Rita J. Director | Grant or award | +9,791 | 56,279 | ||
| 2025-05-15 | Freund John Gordon Director | Grant or award | +9,791 | 62,259 | ||
| 2025-05-15 | SANTINI GINO Director | Grant or award | +9,791 | 85,447 | ||
| 2025-05-15 | Paya Carlos V Director | Grant or award | +19,582 | 19,582 | ||
| 2025-03-21 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −6,396 | $30.03 | $192K | 156,667 |
| 2025-03-21 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −18,881 | $30.03 | $567K | 103,613 |
| 2025-03-20 | Tupper Colleen EVP & Chief Financial Officer | Sale 10b5-1 | −1,206 | $30.00 | $36K | 163,063 |
| 2025-03-20 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −1,927 | $30.00 | $58K | 122,494 |
| 2025-03-17 | Dieter David EVP & General Counsel | Grant or award | +68,449 | 68,449 |
Page 4 of 24 · 462 trades